Effects of realgar (As4S4) on degradation of PML-RARA harboring acquired arsenic-resistance mutations

Ann Hematol. 2017 Nov;96(11):1945-1948. doi: 10.1007/s00277-017-3093-8. Epub 2017 Aug 18.
No abstract available

Publication types

  • Letter

MeSH terms

  • Amino Acid Substitution / drug effects
  • Amino Acid Substitution / genetics
  • Arsenic / therapeutic use*
  • Arsenicals / pharmacology*
  • Arsenicals / therapeutic use
  • Drug Resistance, Neoplasm* / drug effects
  • Drug Resistance, Neoplasm* / genetics
  • HL-60 Cells
  • Humans
  • Inhibitory Concentration 50
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Leukemia, Promyelocytic, Acute / genetics
  • Leukemia, Promyelocytic, Acute / metabolism
  • Mutation, Missense* / physiology
  • Oncogene Proteins, Fusion / genetics
  • Oncogene Proteins, Fusion / metabolism*
  • Proteolysis / drug effects*
  • SUMO-1 Protein / metabolism
  • Sulfides / pharmacology*
  • Sulfides / therapeutic use
  • Sumoylation / drug effects
  • Sumoylation / genetics
  • Tumor Cells, Cultured

Substances

  • Arsenicals
  • Oncogene Proteins, Fusion
  • SUMO-1 Protein
  • Sulfides
  • promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein
  • arsenic disulfide
  • Arsenic